相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
Kurt A. Schalper et al.
NATURE MEDICINE (2019)
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Timothy F. Cloughesy et al.
NATURE MEDICINE (2019)
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Junfei Zhao et al.
NATURE MEDICINE (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual?
E. Antonio Chiocca et al.
NEURO-ONCOLOGY (2019)
Quo Vadis-Do Immunotherapies Have a Role in Glioblastoma?
Sylvia C. Kurz et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2018)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2018)
Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma
Alissa A. Thomas et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Immune checkpoints and their inhibition in cancer and infectious diseases
Lydia Dyck et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
The role of CD44 in glioblastoma multiforme
Kelly L. Mooney et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2016)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
